Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of Gemcitabine Activity With Blue and Red Light.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

Molecular Copper Bipyridine Complex as a Catalyst for Electrochemical Nitrate Reduction.

Inorganic chemistry·2026
Same author

Dissecting the Chemical and Thermal Stabilities of Tetrads in G-Quadruplexes to Derive a Structure-Activity Relation for a Thrombin-Binding DNA G-Quadruplex Aptamer.

Chembiochem : a European journal of chemical biology·2026
Same author

Wash-Free Multi-Target Super-Resolution Microscopy With Photocaged DNA Labels.

Angewandte Chemie (International ed. in English)·2026
Same author

The Role of Chemistry Across Disciplines From Humanities to Life Sciences in Understanding Complexity and Emergence.

Angewandte Chemie (International ed. in English)·2026
Same author

Optical control of Cas9 activity through visible-light cleavable crRNAs.

RSC chemical biology·2026

Related Experiment Video

Updated: May 6, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K

Regulating angiogenesis with light-inducible AntimiRs.

Florian Schäfer1, Jasmin Wagner, Andrea Knau

  • 1Institute for Organic Chemistry and Chemical Biology, Buchmann Institute for Molecular Life Sciences, Goethe-University Frankfurt, Max-von-Laue-Strasse 9, 60438 Frankfurt (Germany).

Angewandte Chemie (International Ed. in English)
|November 1, 2013
PubMed
Summary

Novel antimiRs targeting microRNAs (miRs) can be activated by irradiation to inhibit miR-92a. This approach enhances endothelial cell angiogenesis by derepressing the miR-92a target, integrin α5, for targeted biological activity.

Keywords:
RNAangiogenesisantimiRphotolysis

More Related Videos

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.7K
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

4.6K

Related Experiment Videos

Last Updated: May 6, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K
Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

1.7K
Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases
06:51

Retinal Explant of the Adult Mouse Retina as an Ex Vivo Model for Studying Retinal Neurovascular Diseases

Published on: December 9, 2022

4.6K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • MicroRNA (miRNA) inhibition is crucial for targeted biological activity.
  • Spatiotemporal control of miRNA inhibition can minimize off-target effects.

Purpose of the Study:

  • To develop novel antimiRs against miR-92a.
  • To enable spatiotemporal activation of antimiRs using an exogenous trigger (irradiation).

Main Methods:

  • Design of antimiRs targeting miR-92a.
  • Irradiation-induced activation of antimiRs.
  • Assessment of miR-92a inhibition.
  • Analysis of integrin α5 derepression.
  • Evaluation of endothelial cell angiogenesis.

Main Results:

  • Novel antimiRs against miR-92a were successfully designed and activated by irradiation.
  • Irradiation-mediated inhibition of miR-92a was confirmed.
  • Derepression of the miR-92a target, integrin α5, was observed.
  • Enhanced angiogenesis of endothelial cells was demonstrated.

Conclusions:

  • Irradiation-activated antimiRs provide a spatiotemporally defined method for miRNA inhibition.
  • This strategy effectively targets miR-92a, leading to integrin α5 derepression and enhanced angiogenesis.
  • The approach holds potential for specific therapeutic interventions by controlling biological activity.